These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7807686)

  • 1. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
    Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686
    [No Abstract]   [Full Text] [Related]  

  • 2. Sparfloxacin and levofloxacin.
    Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
    Pneumologie; 1997 Sep; 51(9 Suppl):1-4. PubMed ID: 9417540
    [No Abstract]   [Full Text] [Related]  

  • 4. Prulifloxacin. NAD-441A, NM 441, Quisnon.
    Drugs R D; 2002; 3(6):426-30. PubMed ID: 12516950
    [No Abstract]   [Full Text] [Related]  

  • 5. Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
    Niki Y; Tamada S; Nakabayashi M; Soejima R
    Drugs; 1995; 49 Suppl 2():420-2. PubMed ID: 8549385
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
    Lipsky BA; Dorr MB; Magner DJ; Talbot GH
    Clin Ther; 1999 Jan; 21(1):148-59. PubMed ID: 10090432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 8. Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.
    Goa KL; Bryson HM; Markham A
    Drugs; 1997 Apr; 53(4):700-25. PubMed ID: 9098667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 10. Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
    Norrby SR
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():99-101. PubMed ID: 9484879
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety profile of sparfloxacin in the treatment of respiratory tract infections.
    Rubinstein E
    J Antimicrob Chemother; 1996 May; 37 Suppl A():145-60. PubMed ID: 8737134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG; Owens RC; Quintiliani R; Nightingale CH
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract]   [Full Text] [Related]  

  • 13. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Wadworth AN; Goa KL
    Drugs; 1991 Dec; 42(6):1018-60. PubMed ID: 1724637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
    Stein GE; Havlichek DH
    Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist].
    Schurz JK
    Pharm Unserer Zeit; 2001; 30(5):400-5. PubMed ID: 11575176
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory and clinical study of balofloxacin (Q-35), a new fluoroquinolone, in urinary tract infection.
    Suzuki K; Horiba M; Ishikawa K; Katoh S; Naide Y; Yanaoka M; Andoh S
    Drugs; 1995; 49 Suppl 2():376-8. PubMed ID: 8549367
    [No Abstract]   [Full Text] [Related]  

  • 17. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 18. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of respiratory quinolone in treatment of respiratory tract infections: focusing on gatifloxacin].
    Kohno S; Watanabe A; Matsushima T
    Jpn J Antibiot; 2002 Jun; 55(3):247-58. PubMed ID: 12199109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.